Axon Enterprise (AXON) is up 3.5% today. Here is some analysis on what might have caused this price movement.
Analysis: The most likely driver appears to be continued investor enthusiasm after Axon’s strong second-quarter results and higher full-year outlook. If there was no single fresh announcement today, the move could also reflect follow-through buying as investors digest stronger bookings, rapid software and AI growth, and a wave of higher analyst price targets after earnings.
Details:
Sources:
Axon Investor Relations, Stock Analysis, TipRanks
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$AXON Insider Trading Activity
$AXON insiders have traded $AXON stock on the open market 105 times in the past 6 months. Of those trades, 0 have been purchases and 105 have been sales.
Here’s a breakdown of recent trading of $AXON stock by insiders over the last 6 months:
- PATRICK W SMITH (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 60 sales selling 60,000 shares for an estimated $31,929,275.
- JOSHUA ISNER (PRESIDENT) has made 0 purchases and 19 sales selling 13,000 shares for an estimated $6,349,887.
- BRITTANY BAGLEY (COO & CFO) has made 0 purchases and 7 sales selling 10,235 shares for an estimated $5,253,644.
- ISAIAH FIELDS (Chief Legal Officer) has made 0 purchases and 3 sales selling 4,000 shares for an estimated $1,870,016.
- JENNIFER H MAK (Chief Accounting Officer) sold 1,500 shares for an estimated $860,175
- CAITLIN ELIZABETH KALINOWSKI has made 0 purchases and 9 sales selling 1,494 shares for an estimated $768,019.
- ELIZABETH REID COUGHLIN (Chief Human Officer) sold 1,554 shares for an estimated $753,690
- CAMERON BROOKS (CHIEF REVENUE OFFICER) sold 1,242 shares for an estimated $621,000
- JERI WILLIAMS has made 0 purchases and 3 sales selling 786 shares for an estimated $372,333.
- ERIKA NARDINI sold 198 shares for an estimated $100,302
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$AXON Hedge Fund Activity
We have seen 653 institutional investors add shares of $AXON stock to their portfolio, and 575 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- INVESCO LTD. added 1,994,642 shares (+161.6%) to their portfolio in Q2 2026, for an estimated $1,118,216,251
- BAILLIE GIFFORD & CO added 1,416,909 shares (+86.3%) to their portfolio in Q2 2026, for an estimated $794,333,354
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,083,176 shares (+137.3%) to their portfolio in Q2 2026, for an estimated $607,239,297
- EDGEWOOD MANAGEMENT LLC removed 903,748 shares (-44.6%) from their portfolio in Q2 2026, for an estimated $506,650,166
- CAPITAL WORLD INVESTORS removed 781,518 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $438,126,805
- JENNISON ASSOCIATES LLC removed 742,063 shares (-89.8%) from their portfolio in Q2 2026, for an estimated $416,007,938
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 647,298 shares (+inf%) to their portfolio in Q2 2026, for an estimated $362,881,731
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$AXON Government Contracts
We have seen $122,602,823 of award payments to $AXON over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- THE PURPOSE OF THIS DELIVERY ORDER IS TO PROCURE TASER CORE AND SUSTAINMENT PLANS IN SUPPORT OF ICE- OFFICE...: $5,777,050
- TD 24066 TASER 10 CYCLICAL REPLACEMENT PLUS 6-BAY DOCK AND CORE, CONTRACT - 15M10424DA4700002 SHIPPING IN...: $4,684,195
- INFORMATION TECHNOLOGY DIVISION (ITD) / BODY-WORN CAMERA PROGRAM OFFICE (BWCPO) ENTERPRISE LICENSE AGREEMEN...: $4,377,002
- TASER SUPPLIES FOR CUSTOMS AND BORDER PROTECTION: $3,960,727
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
$AXON Congressional Stock Trading
Members of Congress have traded $AXON stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $AXON stock by members of Congress over the last 6 months:
- SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/27.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
$AXON Analyst Ratings
Wall Street analysts have issued reports on $AXON in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 05/07/2026
To track analyst ratings and price targets for $AXON, check out Quiver Quantitative's $AXON forecast page.
$AXON Price Targets
Multiple analysts have issued price targets for $AXON recently. We have seen 10 analysts offer price targets for $AXON in the last 6 months, with a median target of $687.5.
Here are some recent targets:
- Joshua Reilly from Needham set a target price of $750.0 on 07/06/2026
- Trevor Walsh from Citizens set a target price of $700.0 on 06/25/2026
- Tim Long from Barclays set a target price of $523.0 on 05/08/2026
- James Fish from Piper Sandler set a target price of $674.0 on 05/07/2026
- Joseph Cardoso from JP Morgan set a target price of $755.0 on 05/07/2026
- Andrew Spinola from UBS set a target price of $440.0 on 05/07/2026
- Michael Ng from Goldman Sachs set a target price of $625.0 on 04/08/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.